GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing. GW Pharmaceuticals is Honored to be Named As One of TIME'S 50 Genius Companies GW is the global leader in developing cannabinoid-based medicines. GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis GW Pharmaceuticals PLC Traded as · NASDAQ: GWPH.
plc ) Pharmaceuticals GW (GWPH
The lower, the better 3. A company ranks high with financial strength is likely to withstand any business slowdowns and recessions. Trend of the Operating Margin 5-year average. The company with an uptrend profit margin has a higher rank. Consistency of the profitability 4. Under no circumstances does any information posted on GuruFocus. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations.
The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein.
In no event shall GuruFocus. Past performance is a poor indicator of future performance. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily. FilingWiz Note User Manual. Get 7-Day Free Trial. Click here to check it out. Only PremiumPlus Member can access this feature.
Please enter Portfolio Name for new portfolio. It is based on these factors: A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit. Profitability Rank is not directly related to the Financial Strength Rank.
GW Pharmaceuticals is a British biopharmaceutical company known for its multiple sclerosis treatment product nabiximols brand name, Sativex which was the first natural cannabis plant derivative to gain market approval in any country.
That year they obtained a cultivation license from the United Kingdom Home Office and the MHRA , allowing the company to cultivate cannabis from seeds and clones to conduct scientific research concerning the medicinal uses of the plant.
Nabiximols trade name Sativex is a botanical drug that is a cannabis extract, administered as a mouth spray; it was approved in the UK in as a treatment for multiple sclerosis MS patients to alleviate neuropathic pain , spasticity , overactive bladder, and other symptoms.
Nabiximols is made with two unknown Cannabis strains , and is extracted with ethanol and carbon dioxide. In , GW Pharmaceuticals concluded a partnership with Bayer for the distribution of Sativex in the UK,  and have an estimated annual production of tons of medicinal cannabis since In GW Pharmaceutical initiated Phase 3 clinical trials of cannabidiol by mouth for treatment of two orphan conditions in children — Dravet and Lennox-Gastaut syndromes.
From Wikipedia, the free encyclopedia. Archived from the original on 12 November Archived from the original on 22 July Retrieved 20 January Retrieved 3 February
GW Pharmaceuticals Plc American Depositary Shares (GWPH) Quote & Summary Data
GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a. About: GW Pharmaceuticals plc (GWPH), Includes: APHA, BUD, TLRY, producing products of necessity especially GW Pharmaceuticals plc. About: GW Pharmaceuticals plc (GWPH) GW Pharmaceuticals (GWPH) has seen its approval processes and financing targets met in a very.